The highest frequency of CD14++CD16+ cell counts was, intriguingly, recorded for localized as opposed to metastatic disease which may reflect the preferential induction of intermediate monocytes in the early stages of cancer – a concept which was supported by in vitro studies. The gene discussed is CD14; the disease is metastatic neoplasm.